The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: doxorubicin hydrochloride     Quarter: 2016Q3

Total Drug/Injury Combinations: 406     Number of Pages: 21

DRUGNAME PT EventCount
DOXORUBICIN HYDROCHLORIDE. Visceral leishmaniasis 1 view events
DOXORUBICIN HYDROCHLORIDE. White blood cell count increased 1 view events
DOXORUBICIN HYDROCHLORIDE. Wound 1 view events
DOXORUBICIN HYDROCHLORIDE. Wound dehiscence 1 view events
DOXORUBICIN HYDROCHLORIDE. Wound infection pseudomonas 1 view events
DOXORUBICIN HYDROCHLORIDE. Wound infection staphylococcal 1 view events

Total Drug/Injury Combinations: 406     Number of Pages: 21

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)